A -year-old man is admitted to the intensive care unit with a severe bloodstream infection caused by *Pseudomonas aeruginosa*. He is to be started on an intravenous aminoglycoside. The patient weighs kg. His estimated volume of distribution for the drug is L/kg.
To ensure optimal bactericidal activity and minimize the risk of acute tubular necrosis, the clinical pharmacist recommends targeting a steady-state peak serum concentration of mg/L and a steady-state trough serum concentration of mg/L. Based on the patient's current renal function, the elimination half-life of the drug is determined to be hours.
Assuming the drug follows a one-compartment pharmacokinetic model and distributes instantaneously, what maintenance dose (in mg) must be administered at each dosing interval to achieve these exact steady-state target concentrations?
Answer: 120 mg